Serological response to antipneumococcal vaccination and consequent impact on Streptococcus pneumoniae nasal carriage in HIV positive adults: a prospective study using 13-valent conjugate vaccine [Risposta sierologica alla vaccinazione antipneumococcica e relativo effetto sulla colonizzazione nasale da Streptococcus pneumoniae in adulti HIV positivi: studio prospettico sullefficacia del vaccino coniugato 13-valente]

Trial Profile

Serological response to antipneumococcal vaccination and consequent impact on Streptococcus pneumoniae nasal carriage in HIV positive adults: a prospective study using 13-valent conjugate vaccine [Risposta sierologica alla vaccinazione antipneumococcica e relativo effetto sulla colonizzazione nasale da Streptococcus pneumoniae in adulti HIV positivi: studio prospettico sullefficacia del vaccino coniugato 13-valente]

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2012

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top